Front > Comment > Shiri Habib-Valdhorn

Shiri Habib-Valdhorn

Shiri Habib-Valdhorn  illustration: Gil Gibli Teva, Mylan, Perrigo lose $87b value in 4 years

Shareholders have reason to regret Mylan's rejection of Teva's $40 billion offer, Perrigo's rejection of Mylan's $26 billion offer, and Teva's $40 billion acquisition of Actavis.

Starboard concentrated Waldman's mind

Mellanox founder and CEO Eyal Waldman had been perceived as wanting to keep the company independent.

"Mellanox would fit Broadcom like a glove"

Good results and acquisition rumors sent Mellanox's share price soaring 26.3% in two days.

Copaxone holding its own against generic competition

The market share of Teva's drug as of September 2018 was 77%.

Teva - What a difference a year makes

Tough streamlining, a stablization in generics prices, better than expected performance by Copaxone, and most of all Kare Schultz's leadership, have transformed Teva.

Analysts: Buffett believes Schultz can revive Teva

Teva's share price leaped after it was revealed that Berkshire Hathaway bought a 1.8% stake in the company.

Schultz unfazed by Teva's huge debt

Teva's new CEO has already cut the debt from $34.7 billion at the end of the third quarter to $32.5 billion at the end of 2017.

Analysts reassess Teva

As Teva overtakes Check Point to regain the title of most valuable Israeli company, several analysts have revised previous pessimistic targets.

Will streamlining save Teva?

Financial measures may also be required to ensure Teva's survival.

Will Teva actually manage to make the cuts?

Teva's previous rounds of layoffs have fallen short of the company's targets.

Teva: Right person, wrong time?

Kåre Schultz has turned a company round before, but the challenge at Teva is huge.

Weakened Teva could attract activist investors

After reaching a certain percentage holding in Teva, investment funds could begin demanding changes.

Too many disappointments from Teva

Teva's poor results cut short a rally in its share sparked by good clinical results for its migraine headache drug.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018